Welcome to the investors section of Adocia
Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
- 2020/07/03Half year report on Adocia’s liquidity agreement with Kepler Capital Markets
- 2020/06/05Number of shares and voting rights of ADOCIA as of May 31, 2020
- September 8-11, 2020 Francophone Diabetes Society Congress, Brussels, Belgium - This annual event brings together all members of the French-speaking medical and paramedical community, invested daily in the vast fields of clinical and / or basic diabetology. At this occasion, Adocia will be presenting M1 Pram (ADO09).